Puma Biotechnology PBYI
NASDAQ PBYI
$9.84 -0.09 (-0.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Operating Income (2010 - 2026)

Updated

Puma Biotechnology (PBYI) posted Operating Income of $7.59 million for Q2 2026, up 14.3% from $6.64 million a year earlier.

Analysis

Puma Biotechnology (PBYI) Operating Income (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Income at Puma Biotechnology was $30.44 million, down 33.9% year-over-year; for FY2025, it was $37.3 million, up 20.5% from FY2024.

  • In prior years, Puma Biotechnology's Operating Income was $30.97 million in FY2024 (-5.1%), $32.64 million in FY2023 (+37.6%), $23.72 million in FY2022 and $1.29 million in FY2021.
  • Quarterly Operating Income has run from a low of -$8.95 million in Q3 2021 to a high of $22.08 million in Q3 2024 over five years.
  • On a year-over-year basis, Operating Income increased in three of the last five quarters, with growth averaging 26.6%.
  • The strongest year-over-year quarter for Operating Income in the past five years was Q3 2023, with growth of 258.8%; the weakest was Q2 2023, with a decline of 59.4%.
  • According to Business Quant data, Operating Income for the three prior quarters was -$3.83 million (Q1 2026), $17.11 million (Q4 2025) and $9.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Puma Biotechnology 507.45 Mn 120.09 Mn 44.03 Mn 7.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.59 Mn
Mar 31, 2026 -3.83 Mn
Dec 31, 2025 17.11 Mn
Sep 30, 2025 9.57 Mn
Jun 30, 2025 6.64 Mn
Mar 31, 2025 3.98 Mn
Dec 31, 2024 13.37 Mn
Sep 30, 2024 22.08 Mn
Jun 30, 2024 -2.18 Mn
Mar 31, 2024 -2.30 Mn
Dec 31, 2023 14.80 Mn
Sep 30, 2023 8.59 Mn
Jun 30, 2023 4.89 Mn
Mar 31, 2023 4.37 Mn
Dec 31, 2022 10.02 Mn
Sep 30, 2022 2.39 Mn
Jun 30, 2022 12.06 Mn
Mar 31, 2022 -747,000.00
Dec 31, 2021 6.83 Mn
Sep 30, 2021 -8.95 Mn
API Access

Puma Biotechnology Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=PBYI&period=max&api_key=YOUR_API_KEY